Table 1.
Variable | Characteristics |
---|---|
Age (years) | |
<65 | 713 (83.6%) |
≥65 | 140 (16.4%) |
Gender | |
Male | 780 (91.4%) |
Female | 73 (8.6%) |
Personal Habits | |
Alcohol consumption | 583 (68.3%) |
Betel nut chewing | 699 (81.9%) |
Cigarettes smoking | 716 (83.9%) |
Tumor site | |
Buccal mucosa | 323 (37.9%) |
Tongue | 310 (36.3%) |
Others | 220 (25.8%) |
Overall stage | |
I | 164 (19.2%) |
II | 189 (22.2%) |
III | 129 (15.1%) |
IV | 371 (43.5%) |
pT classification | |
T1 | 194 (22.7%) |
T2 | 286 (33.5%) |
T3 | 91 (10.7%) |
T4 | 282 (33.1%) |
pN classification | |
N0 | 547 (64.1%) |
N1 | 116 (13.6%) |
N2 | 188 (22.0%) |
N3 | 2 (0.3%) |
PNI | 303 (35.6%) |
ENE | 171 (20.1%) |
LVI | 64 (7.5%) |
DOI ≥ 10 mm | 427 (50.1%) |
Surgical margin | |
<5 mm | 260 (30.5%) |
≥5 mm | 593 (69.5%) |
Adjuvant therapy | |
Absent | 366 (42.9%) |
Radiotherapy | 164 (19.2%) |
Chemoradiotherapy | 323 (37.9%) |
Neutrophil (×103 μL−1) § | 5.5 ± 16.5 |
Platelets (×103 μL−1) § | 258.6 ± 92.0 |
Monocyte (×103 μL−1) § | 0.5 ± 0.2 |
Lymphocyte (×103 μL−1) § | 2.0 ± 0.8 |
PIV § | 410.9 ± 1048.9 |
Abbreviations: PNI, perineural invasion; ENE, extranodal extension; LVI, lymphovascular invasion; DOI, depth of invasion; PIV: pan-immune-inflammation value. § Mean ± SD.